UPDATE 1-Senator Grassley seeks info on Novartis's Zolgensma data issues
August 12, 2019 at 18:05 PM EDT
U.S. Senate Finance Committee Chairman Chuck Grassley has asked Swiss drugmaker Novartis AG to provide details on data manipulation related to its $2 million gene therapy, Zolgensma, by Aug. 23.
